Placement proceeds will be used for the development of OroMist® products, the identification and...
CardieX on track to launch new products and digital solutions in 2021
CardieX looks to expand into clinical and consumer markets
SUDA Pharmaceuticals sets sights on development of oral sprays
Only registered members can use this feature.
or
Copyright © Proactive 2021.
All Rights Reserved - Proactive Australia PTY LTD ACN:132787654 ABN:19132787654.
Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use.